The Biotechnology Blog
Biotechnology News
Subscribe to RSS FeedExclusive marketing intelligence for international fund managers (Global Money Management)
AXA Framlington has hired Andy Smith as fund manager to its healthcare team, running AXA Framlington Biotech Fund from April 3. He will report to CEO Robert Kyprianou . Smith joins from venture capital firm SV Life Sciences where he managed the International Biotechnology Trust , a USD203 million global investment trust.
Related Posts:
Fatal error: Call to undefined function related_posts() in /home/leepage2/public_html/biotechnology/wp-content/themes/internet-music-11/internet-music-11/single.php on line 12